Five key publications of the research group:

S. Deleye, J. Verhaeghe, L. Wyffels, S. Dedeurwaerdere, S. Stroobants, S. Staelens. Towards a reproducible protocol for repititive and semi-quantitative rat brain imaging with 18F-FDG: exemplified in a memantine pharmacological challenge. NeuroImage, vol. 96, pp. 276-287, 2014. (SCI=5.895)

Wouters An, Pauwels Bea, Lambrechts Hilde, Pattyn Greet, Ides Johan, Baay Marc, Meijnders Paul, Peeters Marc, Vermorken Jan Baptist, Lardon Filip.- Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient nonsmall-cell lung carcinoma cells. International journal of radiation oncology, biology, physics - 80:2(2011), p. 558-566 S.C.I.: 4.105

Deschoolmeester Vanessa, Baay Marc, Specenier Pol, Lardon Filip, Vermorken Jan Baptist.- A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. The oncologist, 15:7(2010), p. 699-731 S.C.I.: 6.701

Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, André T, Chan E, Lordick F, Punt CJ, Strickland AH, Wilson G, Ciuleanu TE, Roman L, Van Cutsem E, Tzekova V, Collins S, Oliner KS, Rong A, Gansert J. Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer. J Clin Oncol. 2010; 28 (31): 4706-4713 [IF=18.372]

Peeters M, Douillard JY, Van Cutsem E, Siena S, Zhang K, Williams R, Wiezorek J. Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab. J Clin Oncol. 2013;31(6):759-65 [IF=18.372]


The complete academic bibliography for each researcher can be found via 'Members’.